These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3307452)
41. Impact of obesity on insulin action in NIDDM. Campbell PJ; Carlson MG Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411 [TBL] [Abstract][Full Text] [Related]
42. Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes. Hansen BC; Jen KL; Schwartz J Int J Obes; 1988; 12(5):433-43. PubMed ID: 3069766 [TBL] [Abstract][Full Text] [Related]
43. Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals. Pendergrass M; Bertoldo A; Bonadonna R; Nucci G; Mandarino L; Cobelli C; Defronzo RA Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E92-100. PubMed ID: 16896161 [TBL] [Abstract][Full Text] [Related]
45. The effects of short-term overfeeding on adipocyte metabolism in Pima Indians. Kashiwagi A; Mott D; Bogardus C; Lillioja S; Reaven GM; Foley JE Metabolism; 1985 Apr; 34(4):364-70. PubMed ID: 3884965 [TBL] [Abstract][Full Text] [Related]
46. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. Friedman JE; Dohm GL; Leggett-Frazier N; Elton CW; Tapscott EB; Pories WP; Caro JF J Clin Invest; 1992 Feb; 89(2):701-5. PubMed ID: 1737857 [TBL] [Abstract][Full Text] [Related]
47. Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Butler PC; Kryshak EJ; Marsh M; Rizza RA Diabetes; 1990 Nov; 39(11):1373-80. PubMed ID: 2121567 [TBL] [Abstract][Full Text] [Related]
49. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. Bonadonna RC; Del Prato S; Saccomani MP; Bonora E; Gulli G; Ferrannini E; Bier D; Cobelli C; DeFronzo RA J Clin Invest; 1993 Jul; 92(1):486-94. PubMed ID: 8326013 [TBL] [Abstract][Full Text] [Related]
50. Gastric inhibitory polypeptide in obesity and diabetes mellitus. Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812 [TBL] [Abstract][Full Text] [Related]
51. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Mandarino LJ; Consoli A; Jain A; Kelley DE Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694 [TBL] [Abstract][Full Text] [Related]
52. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. Del Prato S; Bonadonna RC; Bonora E; Gulli G; Solini A; Shank M; DeFronzo RA J Clin Invest; 1993 Feb; 91(2):484-94. PubMed ID: 8432857 [TBL] [Abstract][Full Text] [Related]
53. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. Ludvik B; Nolan JJ; Roberts A; Baloga J; Joyce M; Bell JM; Olefsky JM J Clin Invest; 1997 Nov; 100(9):2354-61. PubMed ID: 9410915 [TBL] [Abstract][Full Text] [Related]
54. Insulin receptor binding and metabolic effects of insulin in human subcutaneous adipose tissue in untreated non-insulin dependent diabetes mellitus. Arner P; Engfeldt P; Skarfors E; Lithell H; Bolinder J Ups J Med Sci; 1987; 92(1):47-58. PubMed ID: 3296383 [TBL] [Abstract][Full Text] [Related]
55. Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulin-dependent diabetes mellitus. Segal S; Lloyd S; Sherman N; Sussman K; Draznin B Horm Res; 1990; 34(1):39-44. PubMed ID: 2074090 [TBL] [Abstract][Full Text] [Related]
56. Absorption of rapid-acting insulin in obese and nonobese NIDDM patients. Clauson PG; Linde B Diabetes Care; 1995 Jul; 18(7):986-91. PubMed ID: 7555561 [TBL] [Abstract][Full Text] [Related]
57. Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Bergstrom RW; Newell-Morris LL; Leonetti DL; Shuman WP; Wahl PW; Fujimoto WY Diabetes; 1990 Jan; 39(1):104-11. PubMed ID: 2210052 [TBL] [Abstract][Full Text] [Related]
58. Decreased activation rate of insulin-stimulated glucose transport in adipocytes from obese subjects. Molina JM; Ciaraldi TP; Brady D; Olefsky JM Diabetes; 1989 Aug; 38(8):991-5. PubMed ID: 2666204 [TBL] [Abstract][Full Text] [Related]
59. Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Bogardus C; Taskinen MR; Zawadzki J; Lillioja S; Mott D; Howard BV Diabetes; 1986 Jan; 35(1):1-5. PubMed ID: 3940908 [TBL] [Abstract][Full Text] [Related]
60. Effects of glucose and amino acid infusion on glucose turnover in insulin-resistant obese and type II diabetic patients. Tappy L; Acheson K; Normand S; Pachiaudi C; Jéquier E; Riou JP Metabolism; 1994 Apr; 43(4):428-34. PubMed ID: 8159098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]